CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT07201727 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07201727
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2028-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.